GLP-1 Side Effects Data From Reddit
Evidence & Research Status FDA StatusNot FDA-approved for human use Regulatory StatusResearch Use Only (RUO) — not for human consumption
Research Briefs
Summaries of current peer-reviewed research.
Preserving Lean Mass During GLP-1 Research: What the SEMALEAN Data Showed
SEMALEAN 2026 data shows how lean mass responds during GLP-1 research, and why protein and resistance activity track with muscle preservation.
What the FDA’s July Peptide Meeting Actually Means: 5 Things Every Researcher Should Understand
The plain-talk companion to our July 23–24 FDA advisory meeting explainer. Five things that actually matter for researchers tracking BPC-157, TB-500, and the other peptides under review — framed around evidence, quality, and what a 503A review actually is and isn’t.
Medicare Is Covering GLP-1s for Weight Loss: What This Means for the Future of Obesity Care
Medicare launched a GLP-1 Bridge Program on July 1, 2026 covering select weight-loss medications at $50/month through December 2027. Here is what the program covers, what it signals for the market, and why the maintenance question matters more than the access question.
FDA Is Reviewing Popular Peptides: What Researchers Should Know Before the July 23–24 Advisory Meeting
The FDA advisory committee meets July 23–24 to review seven popular compounding peptides including BPC-157, TB-500, and MOTS-c. Here is what that process means, what is at stake, and why quality sourcing matters more than ever.
5 Questions Smart Researchers Should Ask Before Buying Peptides
The peptide research space moves fast. Before purchasing any compound, these five questions help separate credible sources from hype — covering evidence levels, regulatory status, quality controls, known risks, and supporting variables.
Semaglutide and Biological Aging: What the Epigenetic Clock Data Shows
Update — August 31, 2026 Two developments have moved this subject since publication. First, a randomised 32-week study reported in
Weight Loss vs. Body Composition: Why Muscle Matters During GLP-1 Research
Evidence & Research Status Evidence LevelExtensive Human Clinical Data FDA StatusNot FDA-approved for human use Regulatory StatusResearch Use Only (RUO)
Injectable vs. Oral GLP-1: What Researchers Need to Know
Evidence & Research Status Evidence LevelExtensive Human Clinical Data FDA StatusNot FDA-approved for human use Regulatory StatusResearch Use Only (RUO)
GLP-1 Receptor Agonists and Biological Aging: What the Research Shows
Evidence & Research Status Evidence LevelExtensive Human Clinical Data FDA StatusNot FDA-approved for human use Regulatory StatusResearch Use Only (RUO)